EndoTex Interventional Systems, Inc.

Preliminary results announced from carotid artery stenting study

Published in Surgery Litigation and Law Weekly, October 29th, 2004

EndoTex Interventional Systems announced preliminary 30-day results of the CABERNET trial, a study designed to evaluate the safety and efficacy of carotid artery stenting (CAS) as a minimally invasive alternative for treating carotid artery disease in patients ineligible or at high risk for surgery.

L. Nelson Hopkins, MD, principal investigator of the CABERNET trial, professor and chairman of neurosurgery at the Buffalo State University, presented at the Cardiovascular Research Foundation's 16th annual scientific symposium, Transcatheter Cardiovascular Therapeutics, in Washington DC.

The carotid stenting trial, known as CABERNET, examines the use of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly

Source: Surgery Litigation and Law Weekly (2004-10-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry